Wedbush Morgan Downgrades Dionex (DNEX) to Hold, Citing Valuation
More News related to DNEX
- Dionex Corporation to Present At the UBS Global Life Sciences Conference
- Dionex (DNEX) Tops Q2 View By 6c
- Dionex Reports Record Net Sales and Earnings for the Fourth Quarter
- Dionex Corporation Fourth Quarter & Full Year 2008 Earnings Review Thursday, August 7, 2008, 1:30 p.m. Pacific Time (4:30 p.m. Eastern)
- Wedbush Morgan Downgrades Dionex (DNEX) to Hold, Citing Valuation
More News related to Downgrades
- RBC Capital Downgrades DSP Group (DSPG) to Underperform
- RBC Capital Downgrades Garmin (GRMN) to Underperform
- RBC Capital Downgrades Nortel (NT) to Underperform
- RBC Capital Downgrades Alcatel-Lucent (ALU) to Underperform
- Friedman Billings Downgrades Adobe Systems (ADBE) to Market Perform
Wedbush Morgan downgrades Dionex Corp. (Nasdaq: DNEX) from Buy to Hold with an $81 price target, citing valuation and concerns over European slowdown.
The firm said, "with slowing European market and shift to lower margin mix with Asian market place, we believe shares reflect near term margin expansion."
Related Categories
DowngradesStocks Mentioned
-0.86Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
